191 related articles for article (PubMed ID: 34439480)
1. Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells.
Harandi-Zadeh S; Boycott C; Beetch M; Yang T; Martin BJE; Ren K; Kwasniak A; Dupuis JH; Lubecka K; Yada RY; Howe LJ; Stefanska B
Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439480
[TBL] [Abstract][Full Text] [Related]
2. Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells.
Beetch M; Boycott C; Harandi-Zadeh S; Yang T; Martin BJE; Dixon-McDougall T; Ren K; Gacad A; Dupuis JH; Ullmer M; Lubecka K; Yada RY; Brown CJ; Howe LJ; Stefanska B
J Nutr Biochem; 2021 Dec; 98():108815. PubMed ID: 34242723
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Effects of Resveratrol on Oncogenic Signaling in Breast Cancer.
Kurzava Kendall L; Ma Y; Yang T; Lubecka K; Stefanska B
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474826
[TBL] [Abstract][Full Text] [Related]
4. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity.
Lubecka K; Kurzava L; Flower K; Buvala H; Zhang H; Teegarden D; Camarillo I; Suderman M; Kuang S; Andrisani O; Flanagan JM; Stefanska B
Carcinogenesis; 2016 Jul; 37(7):656-68. PubMed ID: 27207652
[TBL] [Abstract][Full Text] [Related]
5. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression.
Wen H; Li Y; Xi Y; Jiang S; Stratton S; Peng D; Tanaka K; Ren Y; Xia Z; Wu J; Li B; Barton MC; Li W; Li H; Shi X
Nature; 2014 Apr; 508(7495):263-8. PubMed ID: 24590075
[TBL] [Abstract][Full Text] [Related]
6. Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.
Beetch M; Lubecka K; Shen K; Flower K; Harandi-Zadeh S; Suderman M; Flanagan JM; Stefanska B
Mol Nutr Food Res; 2019 Oct; 63(19):e1801386. PubMed ID: 31327173
[TBL] [Abstract][Full Text] [Related]
7. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
8. Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks.
Hahn MA; Wu X; Li AX; Hahn T; Pfeifer GP
PLoS One; 2011 Apr; 6(4):e18844. PubMed ID: 21526191
[TBL] [Abstract][Full Text] [Related]
9. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
Chen CY; Morris Q; Mitchell JA
BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
[TBL] [Abstract][Full Text] [Related]
10. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.
He A; Kong SW; Ma Q; Pu WT
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5632-7. PubMed ID: 21415370
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair.
Li L; Wang Y
J Biol Chem; 2017 Jul; 292(28):11951-11959. PubMed ID: 28546430
[TBL] [Abstract][Full Text] [Related]
13. Activation of muscle enhancers by MyoD and epigenetic modifiers.
Blum R
J Cell Biochem; 2014 Nov; 115(11):1855-67. PubMed ID: 24905980
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
[TBL] [Abstract][Full Text] [Related]
16. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
[TBL] [Abstract][Full Text] [Related]
17. Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells.
Rhie SK; Hazelett DJ; Coetzee SG; Yan C; Noushmehr H; Coetzee GA
BMC Genomics; 2014 May; 15(1):331. PubMed ID: 24885402
[TBL] [Abstract][Full Text] [Related]
18.
Guan Y; Liu H; Ma Z; Li SY; Park J; Sheng X; Susztak K
J Am Soc Nephrol; 2020 Apr; 31(4):765-782. PubMed ID: 32127410
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide mapping of transcriptional enhancer candidates using DNA and chromatin features in maize.
Oka R; Zicola J; Weber B; Anderson SN; Hodgman C; Gent JI; Wesselink JJ; Springer NM; Hoefsloot HCJ; Turck F; Stam M
Genome Biol; 2017 Jul; 18(1):137. PubMed ID: 28732548
[TBL] [Abstract][Full Text] [Related]
20. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
Dreijerink KMA; Groner AC; Vos ESM; Font-Tello A; Gu L; Chi D; Reyes J; Cook J; Lim E; Lin CY; de Laat W; Rao PK; Long HW; Brown M
Cell Rep; 2017 Mar; 18(10):2359-2372. PubMed ID: 28273452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
